secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2022-10-14T23:59:59+00:00
Accession:  0001683168-22-006911
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.08, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PharmaCyte CSO resigns; board sets annual meeting Dec 28, continues $10M buyback
--------------------------------------------------------------------------------

- CSO Gerald W. Crabtree resigned effective Oct 12, 2022; receives $29,694.88 in accrued wages, PTO, and 3 months base salary.
- Board set 2022 Annual Meeting for Dec 28, 2022; director nominations due by Oct 28, 2022.
- Board authorized continuation of up to $10M stock repurchase program; adopted 10b5-1 plan on Oct 13, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316822006911/0001683168-22-006911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316822006911/pharmacyte_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-006911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer